PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-10.86%
Negative net income growth while ZETA stands at 19.26%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
7.92%
D&A growth well above ZETA's 0.39%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-208.20%
Negative yoy deferred tax while ZETA stands at 89.09%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
0.47%
SBC growth while ZETA is negative at -8.64%. John Neff would see competitor possibly controlling share issuance more tightly.
132.15%
Well above ZETA's 135.56% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
115.46%
AR growth well above ZETA's 101.01%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-170.81%
Negative yoy inventory while ZETA is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
121.28%
A yoy AP increase while ZETA is negative at -154.16%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
142.54%
Growth well above ZETA's 240.92%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
134.20%
Some yoy increase while ZETA is negative at -102.22%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
75.32%
Operating cash flow growth above 1.5x ZETA's 33.22%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
8.95%
Some CapEx rise while ZETA is negative at -11.24%. John Neff would see competitor possibly building capacity while we hold back expansions.
-2102.24%
Negative yoy acquisition while ZETA stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-248.22%
Negative yoy purchasing while ZETA stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
118.36%
Liquidation growth of 118.36% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-1226.97%
Both yoy lines negative, with ZETA at -2.74%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-1292.85%
Both yoy lines negative, with ZETA at -11.82%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
63.92%
We slightly raise equity while ZETA is negative at -100.00%. John Neff sees competitor possibly preserving share count or buying back shares.
-18.69%
We cut yoy buybacks while ZETA is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.